SCHEMBL25353042

SCHEMBL25353042

CCN1CCN(Cc2cccc(-c3cn(Cc4ccc(-c5nnc(C(F)F)o5)cc4)nn3)c2)CC1

nearest known ligand 0.53

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
▸ HDAC6 Q9UBN7 4/20 0.53
▸ TEK Q02763 5/20 0.43
▸ KMT2A Q03164 1/20 0.43
▸ KDR P35968 4/20 0.42
▸ HDAC1 Q13547 2/20 0.42
▸ EPHB4 P54760 1/20 0.42
▸ ROCK2 O75116 1/20 0.42
▸ PIM1 P11309 1/20 0.42
▸ GSK3B P49841 1/20 0.42
▸ AURKB Q96GD4 1/20 0.42
▸ ALDH1A1 P00352 1/20 0.41
▸ POLB P06746 1/20 0.41
▸ KCNH2 Q12809 1/20 0.41
▸ GPR55 Q9Y2T6 1/20 0.41
▸ CDC7 O00311 1/20 0.41
▸ CYP19A1 P11511 1/20 0.41
▸ L3MBTL1 Q9Y468 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25993072 0.93 HDAC6 (0.53) HDAC6TEKKDRHDAC1EPHB4
SCHEMBL24215771 0.92 HDAC6 (0.53) HDAC6TEKKDRHDAC1EPHB4
SCHEMBL30409046 0.92 HDAC6 (0.53) HDAC6TEKKDRHDAC1EPHB4
SCHEMBL25350768 0.92 HDAC6 (0.61) HDAC6TEKKMT2AKDRHDAC1
SCHEMBL25347988 0.91 HDAC6 (0.51) HDAC6TEKKDRHDAC1EPHB4
SCHEMBL25351360 0.91 HDAC6 (0.52) HDAC6CDC7
SCHEMBL30409410 0.90 HDAC6 (0.51) HDAC6TEKKMT2AKDRHDAC1
SCHEMBL24216687 0.90 HDAC6 (0.51) HDAC6TEKKMT2AKDRHDAC1
SCHEMBL25351998 0.89 HDAC1 (0.52) HDAC6HDAC1
SCHEMBL25352054 0.89 HDAC6 (0.50) HDAC6TEKKDREPHB4ROCK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230257372-A1 NOVEL COMPOUNDS AS HISTONE DEACETYLASE 6 INHIBITOR, AND PHARMACEUTICAL COMPOSITION COMPRISING THE SAME CHONG KUN DANG PHARMACEUTICAL CORP. (KR) 2023-08-17 — — US disclosed
US-20230257372-A1 NOVEL COMPOUNDS AS HISTONE DEACETYLASE 6 INHIBITOR, AND PHARMACEUTICAL COMPOSITION COMPRISING THE SAME CHONG KUN DANG PHARMACEUTICAL CORP. (KR) 2023-08-17 — — US disclosed
US-20230257372-A1 NOVEL COMPOUNDS AS HISTONE DEACETYLASE 6 INHIBITOR, AND PHARMACEUTICAL COMPOSITION COMPRISING THE SAME CHONG KUN DANG PHARMACEUTICAL CORP. (KR) 2023-08-17 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230257372-A1 NOVEL COMPOUNDS AS HISTONE DEACETYLASE 6 INHIBITOR, AND PHARMACEUTICAL COMPOSITION COMPRISING THE SAME HDAC6, HDAC1, HDAC3 HDAC6 1/4885TEK 3885/4885KMT2A 94/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback